ABSTRACT
BACKGROUND: Prolonged postoperative ileus (PPOI) is associated with higher morbidity and extended inpatient stay. Although evidence suggests that PPOI is more common following right-sided resections, it is uncertain if return to bowel function is similar following extended right (ERH) versus right hemicolectomy (RH). METHODS: The recovery of patients undergoing ERH and RH in a regional hospital in New Zealand was retrospectively compared, from 2012 to 2021. Rates of PPOI, return of bowel function and postoperative complications were compared. Other factors potentially relating to PPOI were analysed. RESULTS: 293 patients were included (42 who underwent ERH, and 251 RH). PPOI was more common following ERH than RH (43% vs. 25%, P = 0.02). When accounting for the operative approach, rate of PPOI was not significantly different (42% open ERH vs. 36% open RH; P = 0.56). Excluding PPOI, return of bowel function did not differ between groups. Patient undergoing ERH versus RH had significantly higher length of stay (1 day) and Hb drop (2.5 g/L) postoperatively. CONCLUSION: Higher rates of PPOI have been demonstrated in ERH versus RH however when controlling for approach, there was not a significant difference. Further interrogation into rates of PPOI (particularly after laparoscopic surgery) are warranted to tailor locoregional ERAS protocols.
Subject(s)
Ileus , Laparoscopy , Humans , Retrospective Studies , Defecation , Colectomy/adverse effects , Colectomy/methods , Laparoscopy/adverse effects , Postoperative Complications/epidemiology , Ileus/epidemiology , Ileus/etiologyABSTRACT
BACKGROUND: The management of lateral pelvic lymph nodes for rectal cancer is a topical and controversial issue. The aim of this study was to assess the relationship between lateral pelvic lymph node features on magnetic resonance imaging (MRI) and positron emission tomography-computed tomography (PET-CT) with oncological outcomes in patients with rectal cancer. METHODS: A retrospective analysis of 284 patients with primary locally advanced rectal cancer treated with neoadjuvant therapy and surgical resection with curative intent between January 2003 and Dec 2018 was undertaken. From this study population, a select cohort of 77 patients with abnormal lateral pelvic lymph nodes on preoperative imaging had imaging re-analysed by radiologists blinded to clinical outcomes. Pre and post neoadjuvant therapy MRI and PET-CT lateral pelvic lymph node features were correlated with oncological outcomes. RESULTS: A lateral pelvic lymph node short axis size ≥5 mm on post neoadjuvant therapy MRI was a significant predictor of worse 3-year local recurrence free survival (HR 8.35, P = 0.001). Lateral pelvic lymph node avidity on post neoadjuvant therapy PET-CT was a significant predictor of worse 3-year distant recurrence free survival (HR 5.62, P = 0.001). No correlation of oncological outcomes with overall survival was identified. CONCLUSION: Lateral pelvic lymph node imaging features on post-neoadjuvant therapy MRI and PET-CT predicted those at risk of rectal cancer recurrence. Further studies are required to confirm these findings that suggest restaging MRI and PET-CT are complementary modalities for the preoperative assessment of lateral pelvic lymph nodes in rectal cancer.
Subject(s)
Positron Emission Tomography Computed Tomography , Rectal Neoplasms , Humans , Positron Emission Tomography Computed Tomography/methods , Retrospective Studies , Neoplasm Recurrence, Local/pathology , Lymph Nodes/pathology , Rectal Neoplasms/diagnostic imaging , Rectal Neoplasms/surgery , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Lymph Node Excision/methodsABSTRACT
PURPOSE: Lateral pelvic lymph node dissection (LPLND) may improve oncological outcomes for select patients with rectal cancer, though functional outcomes may be adversely impacted. The aim of this study is to assess the functional outcomes associated with LPLND for rectal cancer and compare these outcomes with standard surgical resection. METHODS: A systematic search was undertaken to identify relevant studies reporting on urinary dysfunction (UD), sexual dysfunction (SD), and defecatory dysfunction (DD) for patients who underwent LPLND for rectal cancer. Studies comparing functional outcomes in patients who underwent surgery with and without LPLND were assessed. In addition, a comparison of functional outcomes in patients who underwent LPLND before and after the year 2000 was performed. RESULTS: Twenty-one studies of predominantly non-randomised observational data were included. Ten were comparative studies. Male SD was worse in patients who underwent LPLND compared with those who did not (RR 1.68 (95% CI 1.41-1.99, P < 0.001)). No difference was observed for the rate of UD between treatment groups. The rates of UD and male SD in patients who underwent LPLND after the year 2000 were significantly lower than those who underwent LPLND before the year 2000 ((UD) RR = 4.5, p value = 0.0034; male SD RR = 28.7, p value < 0.001). CONCLUSION: Lateral pelvic lymph node dissection is associated with worse male sexual dysfunction compared to standard surgical resection. However, the rates of urine dysfunction and male sexual dysfunction are better in contemporary cohorts which may reflect improved surgical technique and autonomic nerve preservation.
Subject(s)
Neoadjuvant Therapy , Rectal Neoplasms , Humans , Lymph Node Excision/adverse effects , Lymph Node Excision/methods , Lymph Nodes/pathology , Male , Neoplasm Recurrence, Local/surgery , Pelvis/pathology , Pelvis/surgery , Rectal Neoplasms/pathology , Retrospective Studies , Treatment OutcomeABSTRACT
BACKGROUND: Diverting ileostomy (DI) is utilised in rectal cancer surgery to mitigate the effects of anastomotic leak. The aim of this study was to assess the clinical risk factors associated with post-operative complications of DI reversal. METHODS: A single-centre retrospective analysis of patients who underwent surgical resection for rectal cancer and subsequent DI reversal between January 2012 and December 2020 was undertaken. Medical records were reviewed to extract clinical, operative and pathologic details and post-operative complications according to the Clavien-Dindo classification. Univariate and multivariable analyses were undertaken to assess risk factors associated with post-operative complications of DI reversal. RESULTS: One hundred and twenty-six adult patients who underwent DI reversal were included of which 49 had a post-operative complication (39%). The most common complication was prolonged post-operative ileus, which occurred in 24 patients (19%). On multivariable analysis smoking was significantly associated with overall complications (odds ratio [OR] = 5.60, 95% confidence interval [CI] 1.90-16.52, p = 0.0018), and high Clavien-Dindo (2-5) category complications (OR = 4.60, 95% CI 1.81-11.68, p = 0.0013). In addition, patients who received adjuvant chemotherapy were less likely to have a reversal of DI complication (OR = 0.43, 95% CI 0.19-0.94, p = 0.0342) and less likely to have a high Clavien-Dindo (2-5) category complication (OR = 0.44, 95% CI 0.20-0.93, p = 0.0311). CONCLUSION: Smokers who have undergone surgical resection of rectal cancer have a significantly increased risk of post-operative complications after DI reversal. In these patients, the importance of smoking cessation must be emphasised. The decreased complication rate observed in patients who received adjuvant chemotherapy was an unexpected finding.
Subject(s)
Ileostomy , Rectal Neoplasms , Adult , Anastomosis, Surgical , Anastomotic Leak/epidemiology , Anastomotic Leak/etiology , Humans , Ileostomy/adverse effects , Postoperative Complications/epidemiology , Rectal Neoplasms/surgery , Retrospective Studies , SmokersABSTRACT
AIM: Direct-to-surgery rectal resection with lateral pelvic lymph node dissection (LPLND) is a treatment strategy commonly employed in Japan to improve oncological outcomes for rectal cancer. The aim of this study was to assess oncological outcomes in the literature for patients with low rectal cancer who underwent direct-to-surgery resection and LPLND compared with those who underwent total mesorectal excision (TME) alone. METHOD: A literature search of Medline, Embase and PubMed databases was performed to identify relevant studies published between 1989 and 2020. The primary outcomes were 5-year overall survival (OS) and 5-year disease-free survival (DFS). The secondary outcomes were cancer recurrence (local, distant and total) and operative burden (operative time and blood loss). Pooled relative risk (RR) of oncological outcomes was performed using the DerSimonian-Laird method random-effect model. RESULTS: Twenty-one studies fulfilled inclusion criteria, including 19 nonrandomized studies of interventions and two studies from one randomized controlled trial. No differences were observed in 5-year OS or 5-year DFS. Local recurrence in nonrandomized studies was worse in patients who underwent LPLND [RR 1.41 (95% CI 1.21-1.64, p < 0.001)], as was total recurrence [RR 1.44 (95% CI 1.25-1.67, p < 0.001)]. No differences were observed for distant recurrence. CONCLUSION: In the published literature, direct-to-surgery resection with LPLND was associated with worse local and total recurrence. These predominantly nonrandomized data suggest that a nonselective approach to LPLND does not provide optimal management in radiotherapy-naïve patients with low rectal cancer. Further prospective randomized studies with a focus on patient selection are required.
Subject(s)
Clinical Trials as Topic , Neoadjuvant Therapy , Rectal Neoplasms , Humans , Lymph Node Excision , Lymph Nodes , Neoplasm Recurrence, Local/epidemiology , Randomized Controlled Trials as Topic , Rectal Neoplasms/surgery , Retrospective Studies , Treatment OutcomeABSTRACT
PURPOSE: Lateral pelvic lymph node dissection (LPLND) for locally advanced low rectal cancer is a common practice in Japan. However, it is not widely performed in western countries. The aim of this survey study is to assess the current practice and management of lateral pelvic lymph nodes by colorectal surgeons in Australasia. METHODS: The authors developed a survey to assess surgeons' assessment and management of lateral pelvic lymph nodes in patients with rectal cancer. The survey was run through the online RedCap® platform in 2019. An electronic link and request to complete the survey was sent to specialist surgeons of the Colorectal Surgical Society of Australia and New Zealand (CSSANZ). RESULTS: Ninety-two colorectal surgeons completed the online survey (32% response rate). Eighty percent of participants consider malignant lateral pelvic lymph nodes to represent locoregional and resectable disease. In patients with clinically malignant lateral pelvic lymph nodes on preoperative imaging the majority of respondents (92%) recommend neoadjuvant chemoradiotherapy and 86% would also recommend LPLND. Over half of the surgeons (57%) had no exposure to LPLND during fellowship training and approximately two thirds (62%) do not perform LPLND in their current practice. CONCLUSION: This study highlights the challenges in the management of the lateral pelvic lymph nodes in a western context. The majority of the participating Australasian colorectal surgeons consider malignant lateral pelvic lymph nodes to represent locoregional and resectable disease. The majority also recommend LPLND for clinically malignant lateral pelvic nodes. However, adequate training and experience with LPLND is limited.
Subject(s)
Rectal Neoplasms , Surgeons , Humans , Lymph Node Excision , Lymph Nodes/diagnostic imaging , Lymph Nodes/surgery , Neoadjuvant Therapy , Rectal Neoplasms/diagnostic imaging , Rectal Neoplasms/surgerySubject(s)
Lymphangioma, Cystic , Lymphangioma , Humans , Intestine, Small/diagnostic imaging , Intestine, Small/surgery , Lymphangioma/diagnostic imaging , Lymphangioma/surgery , Lymphangioma, Cystic/diagnostic imaging , Lymphangioma, Cystic/surgery , Mesentery/diagnostic imaging , Mesentery/surgerySubject(s)
Appendiceal Neoplasms , Appendix , Cecal Diseases , Endometriosis , Intussusception , Appendix/diagnostic imaging , Appendix/surgery , Cecal Diseases/complications , Cecal Diseases/diagnostic imaging , Endometriosis/complications , Female , Humans , Intussusception/diagnostic imaging , Intussusception/etiologySubject(s)
Rectal Neoplasms , Humans , Lymph Node Excision , Lymph Nodes/surgery , Pelvis , Rectal Neoplasms/surgeryABSTRACT
BACKGROUND: The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) scoring system was developed to aid the diagnosis of necrotizing fasciitis and guide management [1]. AIM: To validate the LRINEC score and identify clinical predictors to develop a refined diagnostic scoring tool for the diagnosis of necrotizing fasciitis at Middlemore Hospital, New Zealand. METHODS: This was a retrospective case-control study of patients admitted to Middlemore Hospital with necrotizing fasciitis and severe cellulitis between January 2000 and December 2010. The LRINEC scores at admission were evaluated for performance in discriminating between cases of necrotizing fasciitis and severe cellulitis. Cases and controls were randomized into developmental and validation cohorts. Univariate and multivariate logistic regression analysis of demographic, clinical, and laboratory variables for the diagnosis of necrotizing fasciitis was performed. The identified independent predictors were used to develop a new diagnostic scoring tool. RESULTS: The area under the receiver operating characteristic curve (C-statistic) of a LRINEC score ≥6 for the diagnosis of necrotizing fasciitis was 0.679. The newly developed SIARI score [Site other than the lower limb, Immunosuppression, Age < 60 years, Renal impairment (creatinine > 141), and Inflammatory markers (CRP ≥ 150, WCC > 25] demonstrated superior diagnostic ability compared with the LRINEC score in both the developmental (C-statistic: 0.832 vs. 0.691, p < 0.001) and validation cohorts (C-statistic: 0.847 vs. 0.667, p < 0.001). CONCLUSION: The LRINEC score exhibited only modest discriminative performance in this cohort, while the SIARI score is a simplified tool that demonstrates superior diagnostic ability for detecting necrotizing fasciitis. Future external validation studies are required to confirm the trends observed in this study.
Subject(s)
Decision Support Techniques , Fasciitis, Necrotizing/diagnosis , Adult , Aged , Fasciitis, Necrotizing/etiology , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk FactorsSubject(s)
Digestive System Surgical Procedures/methods , Intestinal Perforation/etiology , Meckel Diverticulum/complications , Adult , Diagnosis, Differential , Female , Humans , Intestinal Perforation/diagnosis , Intestinal Perforation/surgery , Meckel Diverticulum/diagnosis , Meckel Diverticulum/surgery , Radiography, Abdominal/methodsABSTRACT
BACKGROUND: The aims of this paper were to review our experience with necrotizing fasciitis at Middlemore Hospital and to define the trends in incidence, inpatient mortality and microbiological profile. METHODS: A computerized search of the electronic medical records was undertaken to identify adult patients with a diagnosis of necrotizing fasciitis between January 2000 and December 2010. A retrospective review of the clinical records was performed. RESULTS: Of the 138 patients with necrotizing fasciitis identified, 129 had their diagnosis confirmed at operation. The mortality at 30 days was 20.3% (95% confidence interval (CI) 13.9%-28.0%). There was a significant reduction in hospital mortality in each successive year of the study period with an odds ratio of 0.84 (95% CI 0.71-0.98, P = 0.03). A pattern of increasing incidence was noted until February 2004 (95% CI September 2002-July 2005). This was followed by a significant decrease in incidence. The empirical antibiotic regime of clindamycin, gentamicin and penicillin provides satisfactory cover against 95% of the causative pathogens. CONCLUSION: This represents the largest single-centre published case series in New Zealand. Despite concerns of increasing incidence and mortality associated with necrotizing fasciitis in New Zealand, the experience in South Auckland shows a decrease in incidence of necrotizing fasciitis since 2004 and a statistically significant decreasing trend in hospital mortality.
Subject(s)
Fasciitis, Necrotizing , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Combined Modality Therapy , Fasciitis, Necrotizing/diagnosis , Fasciitis, Necrotizing/epidemiology , Fasciitis, Necrotizing/microbiology , Fasciitis, Necrotizing/therapy , Female , Hospital Mortality , Humans , Incidence , Male , Middle Aged , New Zealand/epidemiology , Retrospective StudiesABSTRACT
AIM: To review the experience of paediatric ovarian masses at Starship Children's Hospital (Auckland, New Zealand). Primarily to assess the range of pathology, the presenting features, and the surgical management of these lesions. METHODS: A search of the hospital surgical pathology database was carried out to identify patients less than 16 years in whom ovarian tissue was submitted for pathological analysis during the 12 year period from January 2000 to December 2011. A retrospective review of the medical records was carried out. RESULTS: 244 ovarian masses in 219 patients were identified. 99 of these were neoplastic with 19 (7.8%) being malignant and an additional four (1.6%) borderline malignant lesions (borderline epithelial tumours). Mature cystic teratoma was the commonest neoplastic lesion (55.6%). Patients who presented with acute abdominal pain were more commonly found to have non-neoplastic lesions than neoplastic lesions (71.5% vs 46.9%, p<0.0001), and those that presented with a palpable mass were more commonly found to have a neoplastic lesion (24.0% vs 3.3%, p<0.0001). Laparoscopic surgery was performed in 41.6% of all patients. Ovary conserving surgery was performed in 56.6% of all patients, though only 32.3% of patients with neoplastic lesions. CONCLUSION: This study provides important insight into the range of ovarian pathology encountered in a New Zealand paediatric population. Most of the ovarian lesions in paediatric age groups are benign. Ovarian sparing surgery is recommended. In cases of ovarian torsion, malignancy in this series and in the literature is less than 2%. This review highlights that paediatric surgical units have vast experience to deal with ovarian pathology in paediatric age groups.